ComplyAdvantage vs Chainalysis

Side-by-side comparison of model-estimated upside.

ComplyAdvantage

-10%

est. 2Y upside i

Series C

Rank

#2543

Sector

RegTech

Est. Liquidity

~2Y

Data Quality

Data: Low

The equity offer is risky and offers low expected upside (-10.4%) over 2 years due to stale valuation, competitive pressure, and expected dilution.

Last updated: July 3, 2026

Chainalysis

+35%

est. 2Y upside i

FinTechSeries D+

Rank

#997

Sector

Fintech

Est. Liquidity

~2Y

Data Quality

Data: Medium

Job candidate should consider equity as high-risk with moderate expected upside.

Last updated: July 19, 2026

Note: These companies have different risk levels. ComplyAdvantage (Higher Risk) and Chainalysis (Moderate Risk). A higher expected upside in a higher-risk company comes with greater uncertainty. Compare within the same risk tier for more meaningful evaluation.

Upside Comparison

Expected Upside

Disclaimer: These rankings are AI-generated estimates and do not constitute financial or career advice. Always conduct your own due diligence.